jens juul holst glp 1 The Story of GLP-1: A Historical Journey in the Treatment of Diabetes and Obesity: 9780443332876: Medicine & Health Science Books @ Jens Juul Holst modtager Lægeforeningens

In the SURPASS-4 trial, adults with T2DM at heightened cardiovascular risk, who were inadequately managed with oral glucose-lowering agents, once-weekly tirzepatide (5 mg, 10 mg, or 15 mg) were compared to insulin glargine (100 U/mL)

Remember when fluoxetine was hailed as a miracle

In contrast, hemoglobin A1c (HbA1c) demonstrates limited diagnostic sensitivity in transplant recipients and should not be used as a standalone diagnostic criterion, particularly in the early post-transplant period, when anemia, fluctuating renal function, and metabolic instability may confound its accuracy ( Screening is advised to begin prior to transplantation, ideally while patients are on the waiting list, to enable early identification of high-risk individuals

Socioeconomic patterns in GLP-1 adoption have become more equitable as compounding pharmacies and direct-to-consumer platforms like PlexusDx have reduced treatment costs by 40 to 60 percent compared to brand-name pharmacy prices